{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:43:30Z","timestamp":1761597810674},"reference-count":53,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00174","type":"journal-article","created":{"date-parts":[[2017,4,2]],"date-time":"2017-04-02T23:43:46Z","timestamp":1491176626000},"update-policy":"http:\/\/dx.doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Deficient Adipogenesis of Scleroderma Patient and Healthy African American Monocytes"],"prefix":"10.3389","volume":"8","author":[{"given":"Rebecca","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Reese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Carmen-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Zemskova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi L.","family":"Helke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Tourkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1046\/j.1523-1755.64.s87.15.x","article-title":"Transforming growth factor beta and progression of renal disease","volume":"87","author":"August","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"B2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","article-title":"PPARs: therapeutic targets for metabolic disease","volume":"26","author":"Berger","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1073\/pnas.0407224102","article-title":"Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides","volume":"102","author":"Bernatchez","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/ncb2696","article-title":"Characterization of the adipocyte cellular lineage in vivo","volume":"15","author":"Berry","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/82176","article-title":"In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation","volume":"6","author":"Bucci","year":"2000","journal-title":"Nat. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1128\/MCB.01421-10","article-title":"The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor \u03b3 through spatial relocalization at helix 7 of its ligand-binding domain","volume":"31","author":"Burgermeister","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/sj.leu.2404996","article-title":"Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L","volume":"22","author":"Christopeit","year":"2008","journal-title":"Leukemia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J. Lipid Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.ATV.21.3.365","article-title":"Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice","volume":"21","author":"Collins","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1172\/JCI28510","article-title":"Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells","volume":"116","author":"Crossno","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/art.23791","article-title":"Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis","volume":"58","author":"Del Galdo","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fcell.2015.00003","article-title":"Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism","volume":"3","author":"Dubland","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/art.20104","article-title":"Disruption of transforming growth factor \u03b2 signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor \u03b3","volume":"50","author":"Ghosh","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B15","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report","volume":"153","author":"Guiducci","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0121930","DOI":"10.1371\/journal.pone.0121930","article-title":"Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model","volume":"10","author":"Hohsfield","year":"2015","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"22910","DOI":"10.1074\/jbc.M703597200","article-title":"Differentiation of human circulating fibrocytes as mediated by transforming growth factor-\u03b2 and peroxisome proliferator-activated receptor \u03b3","volume":"282","author":"Hong","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1096\/fj.05-4295fje","article-title":"Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice","volume":"19","author":"Hong","year":"2005","journal-title":"FASEB J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR-\u03b3 agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1042\/BJ20130580","article-title":"Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPAR\u03b3 pathways","volume":"454","author":"Jiang","year":"2013","journal-title":"Biochem. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s004180050200","article-title":"Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis","volume":"109","author":"Kasper","year":"1998","journal-title":"Histochem. Cell Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/art.30431","article-title":"Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases","volume":"63","author":"Keyszer","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S0006-291X(02)02264-7","article-title":"TGF-\u03b21 induces peroxisome proliferator-activated receptor \u03b31 and \u03b32 expression in human THP-1 monocytes","volume":"297","author":"Kintscher","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10654-005-2210-5","article-title":"Systemic sclerosis mortality in the United States: 1979-1998","volume":"20","author":"Krishnan","year":"2005","journal-title":"Eur. J. Epidemiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1189\/jlb.0403170","article-title":"Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation","volume":"74","author":"Kuwana","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/art.1780400421","article-title":"Racial differences in scleroderma among women in Michigan","volume":"40","author":"Laing","year":"1997","journal-title":"Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2013.07.043","article-title":"Akt and ERK\/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophages","volume":"230","author":"L\u00e1zaro","year":"2013","journal-title":"Atherosclerosis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fphar.2014.00140","article-title":"Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis","volume":"5","author":"Lee","year":"2014a","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"L736","DOI":"10.1152\/ajplung.00210.2013","article-title":"Bleomycin delivery by osmotic mini-pump: similarity to human scleroderma interstitial lung disease","volume":"306","author":"Lee","year":"2014b","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"L736","DOI":"10.1152\/ajplung.00210.2013","article-title":"Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease","volume":"306","author":"Lee","year":"2014c","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13069-015-0028-7","article-title":"Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1","volume":"8","author":"Lee","year":"2015","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B32","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"Leroy","year":"1988","journal-title":"J. Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1194\/jlr.M400049-JLR200","article-title":"Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism","volume":"45","author":"Llaverias","year":"2004","journal-title":"J. Lipid Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/art.10895","article-title":"Endothelin and endothelin receptor antagonists in systemic rheumatic disease","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1038\/oby.2008.331","article-title":"Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype","volume":"16","author":"Nagajyothi","year":"2008","journal-title":"Obesity (Silver. Spring)."},{"key":"B37","first-page":"263","article-title":"Racial variation in clinical and immunological manifestations of systemic sclerosis","volume":"33","author":"Nietert","year":"2006","journal-title":"J. Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fphar.2014.00141","article-title":"Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry","volume":"5","author":"Reese","year":"2014a","journal-title":"Front. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/art.38572","article-title":"Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease","volume":"66","author":"Reese","year":"2014b","journal-title":"Arthritis Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-\u03b3 is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1017\/S1462399410001547","article-title":"Molecular mechanisms controlling human adipose tissue development: insights from monogenic lipodystrophies","volume":"12","author":"Rochford","year":"2010","journal-title":"Expert Rev. Mol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3727\/096368912X639017","article-title":"Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis","volume":"22","author":"Scuderi","year":"2013","journal-title":"Cell Transplant."},{"key":"B43","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/BOR.0b013e328356d9dc","article-title":"Racial differences between blacks and whites with systemic sclerosis","volume":"24","author":"Silver","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"B45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Subcommittee","year":"1980","journal-title":"Arthritis Rheum."},{"key":"B46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/rheumatology\/38.5.397","article-title":"Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans","volume":"38","author":"Tager","year":"1999","journal-title":"Rheumatology (Oxford)."},{"key":"B47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(00)81575-5","article-title":"PPAR\u03b3 promotes monocyte\/macrophage differentiation and uptake of oxidized LDL","volume":"93","author":"Tontonoz","year":"1998","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1755-1536-4-15","article-title":"Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide","volume":"4","author":"Tourkina","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B49","doi-asserted-by":"publisher","first-page":"13879","DOI":"10.1074\/jbc.M412551200","article-title":"Opposing effects of protein kinase Calpha and protein kinase C\u03f5 on collagen expression by human lung fibroblasts are mediated via MEK\/ERK and caveolin-1 signaling","volume":"280","author":"Tourkina","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"L843","DOI":"10.1152\/ajplung.00295.2007","article-title":"Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo","volume":"294","author":"Tourkina","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/ard.2009.117580","article-title":"Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease","volume":"69","author":"Tourkina","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1084\/jem.20061536","article-title":"Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis","volume":"203","author":"Wang","year":"2006","journal-title":"J. Exp. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e13778","DOI":"10.1371\/journal.pone.0013778","article-title":"PPAR\u03b3 downregulation by TGFss in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis","volume":"5","author":"Wei","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:03:50Z","timestamp":1498385030000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":53,"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00174","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]}}}